These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 30250076)

  • 1. Apoptosis and necroptosis in the liver: a matter of life and death.
    Schwabe RF; Luedde T
    Nat Rev Gastroenterol Hepatol; 2018 Dec; 15(12):738-752. PubMed ID: 30250076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lytic cell death in metabolic liver disease.
    Gautheron J; Gores GJ; Rodrigues CMP
    J Hepatol; 2020 Aug; 73(2):394-408. PubMed ID: 32298766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases.
    Chu Q; Gu X; Zheng Q; Wang J; Zhu H
    Anal Cell Pathol (Amst); 2021; 2021():8900122. PubMed ID: 34804779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death and cell death responses in liver disease: mechanisms and clinical relevance.
    Luedde T; Kaplowitz N; Schwabe RF
    Gastroenterology; 2014 Oct; 147(4):765-783.e4. PubMed ID: 25046161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.
    Guo R; Jia X; Ding Z; Wang G; Jiang M; Li B; Chen S; Xia B; Zhang Q; Liu J; Zheng R; Gao Z; Xie X
    Theranostics; 2022; 12(11):5220-5236. PubMed ID: 35836819
    [No Abstract]   [Full Text] [Related]  

  • 6. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necroptosis: an emerging type of cell death in liver diseases.
    Saeed WK; Jun DW
    World J Gastroenterol; 2014 Sep; 20(35):12526-32. PubMed ID: 25253954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Death in Liver Diseases: A Review.
    Shojaie L; Iorga A; Dara L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Mechanisms of Necroptosis in Liver Diseases.
    Xue C; Gu X; Li G; Bao Z; Li L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questions and controversies: the role of necroptosis in liver disease.
    Dara L; Liu ZX; Kaplowitz N
    Cell Death Discov; 2016; 2():16089. PubMed ID: 27924226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A narrative review of the role of necroptosis in liver disease: a double-edged sword.
    Li X; Dong G; Xiong H; Diao H
    Ann Transl Med; 2021 Mar; 9(5):422. PubMed ID: 33842643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial-Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis.
    Yan M; Li H; Xu S; Wu J; Li J; Xiao C; Mo C; Ding BS
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective.
    Shi S; Verstegen MMA; Mezzanotte L; de Jonge J; Löwik CWGM; van der Laan LJW
    Liver Transpl; 2019 Jul; 25(7):1091-1104. PubMed ID: 31077562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell death mechanisms in non-alcoholic steatohepatitis].
    Magusto J; Majdi A; Gautheron J
    Biol Aujourdhui; 2020; 214(1-2):1-13. PubMed ID: 32773025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis.
    Zhou Y; Wu R; Wang X; Bao X; Lu C
    Cell Prolif; 2022 Mar; 55(3):e13193. PubMed ID: 35083817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease.
    Wu W; Hu X; Zhou X; Klenotic PA; Zhou Q; Lin Z
    J Cell Commun Signal; 2018 Mar; 12(1):389-399. PubMed ID: 29214510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.